2-(Tetrahydro-2H-pyran-4-yl)pyrimidine-5-carbaldehyde

Catalog No. :
ACMIBT649
CAS No. :
1484495-55-7
Molecular Formula :
C10H12N2O2
Molecular Weight :
192.22

IUPAC Name:2-(tetrahydro-2H-pyran-4-yl)pyrimidine-5-carbaldehyde

2-(Tetrahydro-2H-pyran-4-yl)pyrimidine-5-carbaldehyde structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
50mg95%$234.00Login to see priceInquiryInquiry
100mg95%$337.00Login to see priceInquiryInquiry
250mg95%$473.00Login to see priceInquiryInquiry
1g95%$941.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-(Tetrahydro-2H-pyran-4-yl)pyrimidine-5-carbaldehyde
IUPAC Name2-(tetrahydro-2H-pyran-4-yl)pyrimidine-5-carbaldehyde
MDL No.MFCD21188374
Molecular FormulaC10H12N2O2
Molecular Weight192.22
SMILESO=CC1=CN=C(C2CCOCC2)N=C1
InChI KeyCEUVQYYMZMISFL-UHFFFAOYSA-N
Synonym5-Pyrimidinecarboxaldehyde, 2-(tetrahydro-2H-pyran-4-yl)-;2-(Tetrahydro-2H-pyran-4-yl)pyrimidine-5-carbaldehyde;2-(Oxan-4-yl)pyrimidine-5-carbaldehyde
CAS No.1484495-55-7
PubChem CID65334514

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P301+P312-P302+P352-P304+P340-P305+P351+P338-P330-P332+P313-P337+P313-P362-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACMIBT649 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACYKDX926 route compound structure diagram
    ACYKDX9261357580-19-8 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACMIBT649 route product structure diagram
    ACMIBT6491484495-55-7
Inquiry

2. ACMIBT649 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACMIBT649 route product structure diagram
    ACMIBT6491484495-55-7
Inquiry

Comments (0)